GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Other Current Payables

Cytophage Technologies (TSXV:CYTO) Other Current Payables : C$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Other Current Payables?

Cytophage Technologies's Other Current Payables for the quarter that ended in Dec. 2024 was C$0.00 Mil.


Cytophage Technologies Other Current Payables Historical Data

The historical data trend for Cytophage Technologies's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Other Current Payables Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Other Current Payables
- - - -

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Cytophage Technologies Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Cytophage Technologies Other Current Payables Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytophage Technologies Business Description

Traded in Other Exchanges
N/A
Address
26 Henlow Bay, Winnipeg, MB, CAN, R3Y 1G4
Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.

Cytophage Technologies Headlines

No Headlines